宏达新材(002211) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥92,648,385.72, a decrease of 23.26% compared to ¥120,733,757.41 in the same period last year[2] - The net profit attributable to shareholders was a loss of ¥10,624,318.28, representing a decline of 117.98% from a loss of ¥4,873,940.08 in the previous year[2] - Total operating revenue for Q1 2022 was ¥92,648,385.72, a decrease of 23.3% compared to ¥120,733,757.41 in the same period last year[23] - Total operating costs for Q1 2022 were ¥103,053,100.65, down 20.1% from ¥128,894,716.74 year-on-year[23] - The net loss for Q1 2022 was ¥10,624,318.28, compared to a net loss of ¥4,873,940.08 in Q1 2021, representing an increase in loss of 117.5%[24] - Basic and diluted earnings per share for Q1 2022 were both -¥0.0246, compared to -¥0.0113 in the previous year[25] Cash Flow and Liquidity - The net cash flow from operating activities improved to ¥61,003,680.16, a significant increase of 182.00% compared to a negative cash flow of ¥74,392,207.60 in the same period last year[2] - Total cash inflow from operating activities is ¥188,077,869.51, while cash outflow is ¥127,074,189.35, resulting in a net cash flow from operations of ¥61,003,680.16[28] - Cash and cash equivalents at the end of the period increased to ¥80,484,326.62 from ¥57,708,757.05 in the previous period, showing a positive change of approximately 39.4%[29] - The company paid ¥98,957,902.37 for goods and services in the current period, down from ¥196,876,373.85 in the previous period, reflecting a decrease of about 49.8%[28] - The cash outflow for investing activities was ¥2,204,056.35, compared to ¥1,033,750.00 in the previous period, indicating an increase of approximately 113.3%[28] - The net cash flow from investing activities is negative at -¥1,428,094.35, worsening from -¥1,019,509.64 in the previous period[28] - Cash inflow from financing activities totaled ¥44,330,001.00, while cash outflow was ¥4,028,516.67, resulting in a net cash flow of -¥4,028,516.67[28] - The company received ¥27,000,000.00 in borrowings during the current period, which is a significant source of cash inflow[28] - The company reported a decrease in tax payments from ¥10,124,814.23 to ¥2,476,801.99, a reduction of approximately 75.6%[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥504,706,938.02, down 2.44% from ¥517,305,210.83 at the end of the previous year[2] - Total liabilities at the end of Q1 2022 were ¥462,304,031.07, slightly down from ¥464,277,985.60 in the previous period[21] - The equity attributable to shareholders decreased by 20.04% to ¥42,402,906.95 from ¥53,027,225.23 at the end of the previous year[2] - The company's total equity attributable to shareholders was ¥42,402,906.95, down from ¥53,027,225.23 in the previous period[21] Operational Highlights - The company reported a cash balance of ¥287,840,046.26 as of March 31, 2022, an increase from ¥207,910,125.62 at the beginning of the year, reflecting a growth of approximately 38.4%[19] - Accounts receivable decreased significantly to ¥5,552,348.34 from ¥48,719,526.30, indicating a reduction of about 88.6%[19] - The company’s inventory increased to ¥47,539,655.65 from ¥41,039,132.17, representing a growth of approximately 15.9%[19] - The company received government subsidies amounting to ¥415,311.59 during the reporting period[5] Management and Governance - The company appointed a new CFO, Wang Yanjie, on February 16, 2022, to oversee financial operations[13] - The company is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws[12] - The company’s major shareholder, Jiangsu Weilen Investment Management Co., had 28,325,124 shares frozen due to an investigation by the local disciplinary committee[12] Strategic Initiatives - The company is engaged in a strategic cooperation agreement for three years with Inner Mongolia Hengxing Chemical Co., focusing on the supply of various silicone products[16] - The company’s subsidiary, Dongguan New Oriental Technology Co., signed a strategic cooperation agreement with Inner Mongolia Hengxing Chemical Co. for the supply of silicone products[16] - The company plans to auction off remaining assets with an estimated value of ¥1,304.45 million, but the first two auctions failed to attract bidders[17] Research and Development - Research and development expenses for Q1 2022 were ¥4,307,019.86, a decrease of 30.6% from ¥6,204,300.57 in the same period last year[23] Audit and Compliance - The company did not conduct an audit for the first quarter report, indicating that the figures are unaudited[29]